Suppr超能文献

设计、合成及三芳基化合物作为新型 20S 蛋白酶体抑制剂的生物评价。

Design, synthesis and biological evaluation of triaryl compounds as novel 20S proteasome inhibitors.

机构信息

Beijing Key Laboratory of Active Substance Discovery and Druggability Evaluation, Institute of Material Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.

The State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Material Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.

出版信息

Bioorg Med Chem Lett. 2020 Nov 1;30(21):127508. doi: 10.1016/j.bmcl.2020.127508. Epub 2020 Aug 24.

Abstract

Thirty novel triaryl compounds were designed and synthesized based on the known proteasome inhibitor PI-1840. Most of them showed significant inhibition against the β5c subunit of human 20S proteasome, and five of them exhibited IC values at the sub-micromolar level, which were comparable to or even more potent than PI-1840. The most active two (1c and 1d) showed IC values of 0.12 and 0.18 μM against the β5c subunit, respectively, while they displayed no obvious inhibition against the β2c, β1c and β5i subunits. Molecular docking provided informative clues for the subunit selectivity. The potent and subunit selective proteasome inhibitors identified herein represent new chemical templates for further molecular optimization.

摘要

基于已知的蛋白酶体抑制剂 PI-1840,我们设计并合成了 30 种新型三芳基化合物。它们大多数对人 20S 蛋白酶体的β5c 亚基表现出显著的抑制作用,其中 5 种化合物的 IC 值达到亚微摩尔水平,与 PI-1840 相当甚至更有效。活性最高的两种(1c 和 1d)对β5c 亚基的 IC 值分别为 0.12 和 0.18 μM,而对β2c、β1c 和β5i 亚基则没有明显的抑制作用。分子对接为亚基选择性提供了有价值的线索。本文鉴定的强效和亚基选择性蛋白酶体抑制剂代表了进一步分子优化的新化学模板。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验